Characteristics of Ventricular Tachycardia Ablation in Patients with Continuous Flow Left Ventricular Assist Devices

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 3, 2015, Pages 592-597

  Sacher, Frederic ^a   Reichlin, Tobias ^b   Zado, Erica S ^c   Field, Michael E ^c   Viles Gonzalez, Juan F ^e   Peichl, Petr ^f   Ellenbogen, Kenneth A ^g   Maury, Philippe ^h   Dukkipati, Srinivas R ⁱ   Picard, Francois ^a   Kautzner, Josef ^f   Barandon, Laurent ^a   Koneru, Jayanthi N ^g   Ritter, Philippe ^a   Mahida, Saagar ^b   Calderon, Joachim ^a   Derval, Nicolas ^a   Denis, Arnaud ^a   Cochet, Hubert ^a   Shepard, Richard K ^g   Corre, Jerome ^a   Coffey, James O ^e   Garcia, Fermin ^c   Hocini, Meleze ^a   Tedrow, Usha ^b   Haissaguerre, Michel ^a   D'Avila, Andre ⁱ   Stevenson, William G ^b   Marchlinski, Francis E ^d   Jais, Pierre ^a   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d University of Wisconsin Health   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ MOUNT SINAI HOSPITAL   (United States)

Author keywords

ablation; ventricular arrhythmia; ventricular assist device; ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN;

ACIDOSIS; ADULT; AGED; AORTA; ARTICLE; CANNULA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GROIN HEMATOMA; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; MALE; MIDDLE AGED; NONISCHEMIC CARDIOMYOPATHY; PATHOGENESIS; PATIENT SAFETY; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; ACTION POTENTIAL; ADVERSE EFFECTS; EUROPE; FEASIBILITY STUDY; HEART ASSIST DEVICE; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; TACHYCARDIA, VENTRICULAR; TERTIARY CARE CENTER; TIME; UNITED STATES;

ACTION POTENTIALS; AGED; CATHETER ABLATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EUROPE; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84942856270     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.114.002394     Document Type: Article

References (20)

1. Bank AJ, Mir SH, Nguyen DQ, Bolman RM III, Shumway SJ, Miller LW, Kaiser DR, Ormaza SM, Park SJ. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg. 2000;69:1369-74; discussion 1375.
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443. doi: 10.1056/NEJMoa012175.
3. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428-1434. doi: 10.1016/j.jacc.2005.01.035.
4. Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008;31:1246-1252. doi: 10.1111/j.1540-8159.2008.01173.x.
5. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151-1153. doi: 10.1016/j.amjcard.2006.11.051.
6. Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466-471. doi: 10.1016/j.hrthm.2009.12.022.
7. Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013;6:668-674. doi: 10.1161/CIRCEP.113.000457.
8. Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, Sheridan BC, Bowen A, Katz JN. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373-378. doi: 10.1016/j.ahj.2012.06.018.
9. Maury P, Delmas C, Trouillet C, Slaughter MS, Lairez O, Galinier M, Roncalli J, Bertrand D, Mathevet L, Duparc A, Salvador M, Delay M, Dambrin C. First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device. J Interv Card Electrophysiol. 2010;29:63-67. doi: 10.1007/s10840-010-9476-6.
10. Cantillon DJ, Bianco C, Wazni OM, Kanj M, Smedira NG, Wilkoff BL, Starling RC, Saliba WI. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm. 2012;9:859-864. doi: 10.1016/j.hrthm.2012.01.018.
11. Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar D, Karlnosky R, Barold SS. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol. 2012;35:1377-1383. doi: 10.1111/j.1540-8159.2012.03509.x.
12. Sheikh FH, Russell SD. HeartMate® II continuous-flow left ventricular assist system. Expert Rev Med Devices. 2011;8:11-21. doi: 10.1586/ erd.10.77.
13. Cochet H, Komatsu Y, Sacher F, Jadidi AS, Scherr D, Riffaud M, Derval N, Shah A, Roten L, Pascale P, Relan J, Sermesant M, Ayache N, Montaudon M, Laurent F, Hocini M, Haïssaguerre M, Jaïs P. Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol. 2013;24:419-426. doi: 10.1111/ jce.12052.
14. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4:1165-1169. doi: 10.1016/j.hrthm.2007.05.029.
15. Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D, Takayama H, Naka Y, Garan H, Jorde UP, Uriel N. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol. 2013;61:2542-2550. doi: 10.1016/j. jacc.2013.04.020.
16. Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819-825. doi: 10.1016/j.healun.2007.05.011.
17. Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S, Kern JA. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg. 2013;145:1207-1213. doi: 10.1016/j.jtcvs.2012.03.061.
18. Rohit M, Charles JL, Sai-Sudhakar C, Hasan AK, Chan D. A device-device interaction between a Thoratec Heartmate II left ventricular assist device and a St. Jude Atlas (V-193) implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18:E27; author reply E28. doi: 10.1111/j.1540-8167.2007.00949.x.
19. Matthews JC, Betley D, Morady F, Pelosi F Jr. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18:1107-1108. doi: 10.1111/j.1540-8167.2007.00805.x.
20. Boudghène-Stambouli F, Boulé S, Goéminne C, Botcherby E, Marquié C, Kouakam C, Guédon-Moreau L, Schurtz G, de Groote P, Lamblin N, Fertin M, Robin E, Brigadeau F, Klug D, Lacroix D, Meurice J, Wissocque L, Vincentelli A, Kacet S. Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2014;39:177-184. doi: 10.1007/ s10840-013-9854-y.